(75 days)
The VISUCAM™ PRO NM Digital Camera is suitable for photographing, displaying and storing the data of the retina and surrounding parts of the eye to be examined under mydriatic and non-mydriatic conditions. These photographs support the diagnosis and subsequent observation of eye diseases which can be visually monitored and photographically documented.
The VISUCAM™ PRO NM Digital Camera is intended to capture, display and store images of the eye, especially the retinal area, as well as surrounding areas, to aid in diagnosing or monitoring diseases of the eye that may be observed and photographed. The VISUCAM™ PRO NM Digital Camera is indicated for use in non-mydriatic mode. As such, it incorporates appropriate light sources so that retinal areas of interest may be observed under non-mydriatic conditions and images may be captured with a flash illumination.
This is a premarket notification (510k) for the Carl Zeiss Meditec VISUCAM™ PRO NM Digital Camera, which is a medical imaging device (specifically, an ophthalmic camera).
The provided text does not contain acceptance criteria, a study proving device performance against acceptance criteria, or details regarding AI/algorithm performance.
A 510(k) submission primarily demonstrates substantial equivalence to a legally marketed predicate device. In this case, the VISUCAM™ PRO NM Digital Camera is shown to be substantially equivalent to the VISUCAM™ C Digital Camera (K043222). This type of submission generally relies on demonstrating that the new device has the same intended use, technological characteristics, and performs as safely and effectively as the predicate device. It does not typically involve extensive clinical studies with specific performance metrics and acceptance criteria in the way an AI/ML medical device submission would.
Therefore, I cannot populate the requested table or provide answers to the questions regarding acceptance criteria, study details, sample sizes, expert involvement, adjudication methods, MRMC studies, standalone performance, or ground truth for training/test sets. These concepts are not addressed in this 510(k) submission.
The document states: "As described in this 510(k) Summary, all testing deemed necessary was conducted on the VISUCAM™ PRO NM Digital Camera to ensure that the device is safe and effective for its intended use when used in accordance with its Instructions for Use." However, it does not detail what "all testing deemed necessary" entailed or any specific performance targets.
{0}------------------------------------------------
Carl Zeiss Meditec Visucam PRO NM Special 510(k) Notification
NOV - 2 2005
510(k) SUMMARY
VISUCAM™ PRO NM Digital Camera
This 510(k) summary for the VISCUCAM™ PRO NM Digital Camera is submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92 .
GENERAL INFORMATION
| Manufacturer: | Carl Zeiss Meditec AGGöschwitzer Strasse 51 - 5207740 JenaGermanyEst. Reg. No. 9615030 |
|---|---|
| Contact Person: | Michael GiebeRA-Manager |
| U.S. Designated Agent: | Kent W. JonesVice President, RA/CA/ComplianceCarl Zeiss Meditec Inc.5160 Hacienda DriveDublin, California 94568(925) 557-4353 (phone)(925) 557-4481 (fax) |
DEVICE DESCRIPTION
| Classification: | Class II |
|---|---|
| Trade Name: | VISUCAM™ PRO NM Digital Camera |
| Regulation Name/No.: | Camera, Ophthalmic, AC-powered; (21 CFR § 886.1120) |
| Product Code: | HKI |
PREDICATE DEVICE VISUCAM™ C Digital Camera (K043222)
000158
{1}------------------------------------------------
Carl Zeiss Meditec Visucam PRO Special 510(k) Notification
INTENDED USE
The VISUCAM™ PRO NM Digital Camera is suitable for photographing, displaying and storing the data of the retina and surrounding parts of the eye to be examined under mydriatic and non-mydriatic conditions. These photographs support the diagnosis and subsequent observation of eye diseases which can be visually monitored and photographically documented.
DEVICE DESCRIPTION
The VISUCAM™ PRO NM Digital Camera is intended to capture, display and store images of the eye, especially the retinal area, as well as surrounding areas, to aid in diagnosing or monitoring diseases of the eye that may be observed and photographed. The VISUCAM™ PRO NM Digital Camera is indicated for use in non-mydriatic mode. As such, it incorporates appropriate light sources so that retinal areas of interest may be observed under non-mydriatic conditions and images may be captured with a flash illumination.
SUBSTANTIAL EQUIVALENCE
The VISUCAM™ PRO NM Digital Camera is substantially equivalent to the VISUCAM™ C Digital Camera (K043222) because it is a modification of this ophthalmic camera. Both devices are intended for examination and capturing images of the eye and incorporate features, such as light sources, sensors, and filters, in order to function in accordance with their respective intended uses.
CONCLUSION
As described in this 510(k) Summary, all testing deemed necessary was conducted on the VISUCAM™ PRO NM Digital Camera to ensure that the device is safe and effective for its intended use when used in accordance with its Instructions for Use.
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of a caduceus, a symbol often associated with healthcare, featuring a staff with a serpent entwined around it.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
NOV - 2 2005
Carl Zeiss Meditec AG c/o Kent W. Jones Vice President, RA/CA/Compliance 5160 Hacienda Drive Dublin, GA 94568
Re: K052268
Trade/Device Name: VISUCAM™ PRO NM Digital Camera Regulation Number: 21 CFR 886.1120 Regulation Name: Ophthalmic Camera Regulatory Class: Class II Product Code: HKI Dated: October 20, 2005 Received: October 21, 2005
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Iisting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
{3}------------------------------------------------
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 827-8910. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours.
David M. Whipple
David M. Whipple Acting Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
Carl Zeiss Meditec Visucam™ PRO NM Special 510(k) Notification
STATEMENT OF INDICATIONS FOR USE
510(k) Number (if known): K 05 ≥ 2 6 8 VISUCAM™ PRO NM Digital Camera Device Name:
Indications for Use:
The VISUCAM PRO NM Digital Camera is suitable for photographing, displaying and storing the data of the retina and surrounding parts of the eye to be examined under mydriatic and non-mydriatic conditions. These photographs support the diagnosis and subsequent observation of eye diseases which can be visually monitored and photographically documented.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use
(Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
Dozul
10/30/200
ision Sion-Off vision of Onhthalmic Nose and Throat Dr
510(k) Number K052268
§ 886.1120 Ophthalmic camera.
(a)
Identification. An ophthalmic camera is an AC-powered device intended to take photographs of the eye and the surrounding area.(b)
Classification. Class II (special controls). The device, when it is a photorefractor or a general-use ophthalmic camera, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 886.9.